Immunotherapy versus targeted therapy in the adjuvant setting for resected stage III melanoma: A single institution study.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Cleveland Clinic, Cleveland Clinic Lerner College of Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281737022
